EUA
C-Sync COVID-19 Antigen Test
FDA Emergency Use Authorization · Biosynchronicity Corporation · Sep 20, 2023
Key facts
| Product | C-Sync COVID-19 Antigen Test |
|---|---|
| Company | Biosynchronicity Corporation |
| Product type | Lateral Flow, Visual Read, Serial Screening, Multiple Targets |
| Date | Sep 20, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: